SDRI NEWS
SDRI NEWS
SDRI Welcomes Dr. Andrew Koutnik to Spearhead Diabetes Research and Nutrition
Sansum Diabetes Research Institute (SDRI), a global organization dedicated to advancing diabetes research and improving the lives of individuals affected by diabetes, is delighted to announce the appointment of Andrew Koutnik, PhD, as a Research Scientist. Dr. Koutnik brings a wealth of knowledge and expertise in metabolic therapies for health, disease, and performance outcomes in the field of diabetes to SDRI. Dr. Koutnik is also a patient advocate who lives with type 1 diabetes.
Taste of the Vine Returns with Live Event to Benefit SDRI
BREAKING NEWS: Dexcom G7 Continuous Glucose Monitor has received FDA approval! SDRI conducted the pivotal clinical research trials for the G7 Continuous Glucose Monitor
2023 Q2 Newsletter
Learn more about what Sansum Diabetes Research Institute has been up to this quarter!
SDRI Announces Appointment of Dr. Kenneth Waxman as New Board President
BREAKING NEWS: Dexcom G7 Continuous Glucose Monitor has received FDA approval! SDRI conducted the pivotal clinical research trials for the G7 Continuous Glucose Monitor
Sansum Diabetes Research Institute Unveils 2022 Annual Report
BREAKING NEWS: Dexcom G7 Continuous Glucose Monitor has received FDA approval! SDRI conducted the pivotal clinical research trials for the G7 Continuous Glucose Monitor
2023 E-Newsletter
Learn more about what Sansum Diabetes Research Institute has been up to this quarter!
Contact
2219 Bath Street
Santa Barbara, CA 93105
Phone: 805-682-7638
Fax: 805-682-3332
Patient Care: 805-682-4793
Tax ID # 95-1684086
